ArticleBlood advances2022
High-sensitivity next-generation sequencing MRD assessment in ALL identifies patients at very low risk of relapse.
Nicholas J Short et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
57 papers cite it
this papertrialcites it